Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B

Grade Last Price % Change Price Change
grade C 210.7108 -6.35% -14.29
BIO.B closed down 6.35 percent on Monday, August 21, 2017, on 84 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical BIO.B trend table...

Date Alert Name Type % Chg
Aug 21 NR7 Range Contraction 0.00%
Aug 21 Narrow Range Bar Range Contraction 0.00%
Aug 18 50 DMA Resistance Bearish -6.35%
Aug 18 1,2,3 Retracement Bearish Bearish Swing Setup -6.35%
Aug 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.35%

Older signals for BIO.B ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO.B a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 240.5
52 Week Low 138.37
Average Volume 440
200-Day Moving Average 196.3742
50-Day Moving Average 226.4842
20-Day Moving Average 228.9456
10-Day Moving Average 223.5711
Average True Range 6.2631
ADX 45.09
+DI 5.29
-DI: 21.97
Chandelier Exit (Long, 3 ATRs) 221.7107
Chandelier Exit (Short, 3 ATRs) 229.5001
Upper Bollinger Band 243.0697
Lower Bollinger Band 214.8215
Percent B (%b) -0.15
Bandwidth 0.123384
MACD Line -2.1851
MACD Signal Line -0.4875
MACD Histogram -1.6976